TME

Tencent Music Entertainment Group
$8.38
+0.42 (+5.28%)
Mkt Cap 12.88B
Volume 9,570,538
52W Range 7.66-23.86
Sector Communication Services
Beta 0.75
EPS (TTM) 0.83 USD
P/E Ratio 10.07
Revenue (TTM) 4.94B USD
Rev Growth (5Y) +2.4%
EPS Growth (5Y) +22.9%
AlphaVal · Fair Value
What we estimate one share is worth
$21.67
Undervalued strong signal
61.3% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Platform & Compounding FCF
74.1 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 32.90B 28.40B 27.75B 28.34B 31.24B 29.15B 25.43B 18.98B 10.98B 4.36B
Net Income 11.06B 6.64B 4.92B 3.68B 3.03B 4.16B 3.98B 1.83B 1.33B 82.00M
EPS 7.00 4.30 3.16 2.30 1.82 2.50 2.44 1.19 0.82 0.05
Free Cash Flow 9.86B 9.24B 6.17B 6.43B 2.48B 4.38B 5.91B 5.49B 2.42B 832.00M
FCF / Share 6.43 5.90 3.90 4.01 1.49 2.65 3.61 3.57 1.49 0.51
Operating CF 10.16B 10.28B 7.34B 7.48B 5.24B 4.88B 6.20B 5.63B 2.50B 873.00M
Total Assets 102.59B 90.44B 75.54B 67.01B 67.25B 68.27B 7.56B 44.60B 30.00B 23.54B
Total Debt 3.82B 6.05B 6.05B 5.96B 5.36B 5.50B 21.10M 0 0 0
Cash & Equiv 8.49B 13.16B 13.57B 9.55B 6.59B 11.13B 2.21B 17.36B 5.17B 3.07B
Book Value 80.34B 67.86B 55.91B 48.10B 50.32B 52.24B 6.26B 37.72B 26.14B 20.62B
Return on Equity 0.14 0.10 0.09 0.08 0.06 0.08 0.64 0.05 0.05 0.00
TME News
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
Oct 05, 2026 04:00 AM · gurufocus.com
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Oct 01, 2026 11:00 PM · gurufocus.com
Major Indexes Slide as Investors Digest Consumer Sentiment Data
Sep 29, 2026 07:55 AM · schaeffersresearch.com
Tencent Music: The Market Is Pricing In Too Much Weakness
Sep 15, 2026 11:56 PM · seekingalpha.com
Tencent Music's 2026 Outlook: $400 Million Share Repurchase Program Reflects Financial Discipline
Sep 15, 2026 08:00 PM · fool.com
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
Sep 13, 2026 04:00 AM · gurufocus.com
Tencent Music Entertainment Group Announces Closing of US$1,000 Million Notes Offering
Sep 10, 2026 03:00 PM · prnewswire.com
BIGBANG 2026-2027 WORLD TOUR < XX: COSMOS > IN HONG KONG Officially Announced
Sep 07, 2026 11:00 PM · gurufocus.com
Tencent Music Entertainment Group Announces Pricing of US$1,000 Million Notes Offering
Sep 03, 2026 12:15 PM · prnewswire.com
Tencent Music Entertainment Group Announces Notes Offering
Sep 01, 2026 12:35 PM · prnewswire.com